Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Step 4 : Post-injection care Apply pressure: Use a cotton ball or gauze to apply gentle pressure and massage to the injection site
Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found
Genetic predispositions in GIPR, FTO, and MC4R may help provide context for how your body's incretin and appetite pathways function
Maximum savings limits: $100 per 1-month prescription $200 per 2-month prescription $300 per 3-month prescription Annual savings cap: $1,300 per calendar year
Key Metrics & Financial Highlights Metric Value Year 1 Revenue $600-800K Year 3 Revenue $10-18M LTV:CAC Ratio 9.8:1 Gross Margin 66% Target Exit Valuation $60-100M (Years 3-4) Initial Capital Required $50-75K MARKET OPPORTUNITY Market Size & Growth Current market: 12 million Americans on GLP-1 medications 2026 projection: 15+ million users Growth rate: 25% annually Patient spend: $900-1,500/month per patient on medication alone Search intent: 50,000+ monthly searches for GLP-1 nutrition solutions Total Addressable Market 12M users 30% willing to pay = 3.6M addressable customers 3.6M $65/month 12 months = $2.8B annual TAM Conservative penetration of 5-10% = $140-280M realistic market Year 1 serviceable market: 1-2% = $28-56M The Problem GLP-1 patients face three critical, interconnected problems: 1
Rosaly understands that the first week can bring a mix of excitement and questions, which is why she emphasizes a customized plan for every individual
US$ 23.60
US$ 26.81
US$ 20.31
US$ 29.46
US$ 20.80
